Champions Oncology Dirección
Dirección controles de criterios 4/4
El CEO de Champions Oncology's es Ronnie Morris , nombrado en Jan 2017, tiene una permanencia de 7.25 años. compensación anual total es $600.00K, compuesta por 66.7% salario y 33.3% primas, incluidas acciones y opciones de la empresa. posee directamente un 6.32% de las acciones de la empresa, por valor de $4.35M. La antigüedad media del equipo directivo y de la junta directiva es de 2.6 años y 12.8 años, respectivamente.
Información clave
Ronnie Morris
Chief Executive Officer (CEO)
US$600.0k
Compensación total
| Porcentaje del salario del CEO | 66.7% |
| Permanencia del CEO | 7.3yrs |
| Participación del CEO | 6.3% |
| Permanencia media de la dirección | 2.7yrs |
| Promedio de permanencia en la Junta Directiva | 12.9yrs |
Actualizaciones recientes de la dirección
Recent updates
Is Now The Time To Put Champions Oncology (NASDAQ:CSBR) On Your Watchlist?
Sep 28
Champions Oncology Non-GAAP EPS of -$0.02, revenue of $12.9M
Jul 21We Think Some Shareholders May Hesitate To Increase Champions Oncology, Inc.'s (NASDAQ:CSBR) CEO Compensation
Oct 14We Think Champions Oncology (NASDAQ:CSBR) Can Afford To Drive Business Growth
Jun 21Are Investors Undervaluing Champions Oncology, Inc. (NASDAQ:CSBR) By 44%?
Apr 09Here's Why We're Not At All Concerned With Champions Oncology's (NASDAQ:CSBR) Cash Burn Situation
Mar 19The Champions Oncology (NASDAQ:CSBR) Share Price Has Gained 243%, So Why Not Pay It Some Attention?
Mar 02Is There Now An Opportunity In Champions Oncology, Inc. (NASDAQ:CSBR)?
Feb 04Do Insiders Own Lots Of Shares In Champions Oncology, Inc. (NASDAQ:CSBR)?
Jan 14Philip Breitfeld Is The Chief Strategy & Innovation Officer and Director of Champions Oncology, Inc. (NASDAQ:CSBR) And They Just Sold 100% Of Their Shares
Dec 19Champions Oncology, Inc. (NASDAQ:CSBR) Analysts Are Pretty Bullish On The Stock After Recent Results
Dec 16
Champions Oncology beats on revenue
Dec 14Estimating The Fair Value Of Champions Oncology, Inc. (NASDAQ:CSBR)
Dec 04Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Jan 31 2024 | n/a | n/a | -US$10m |
| Oct 31 2023 | n/a | n/a | -US$10m |
| Jul 31 2023 | n/a | n/a | -US$8m |
| Apr 30 2023 | US$600k | US$400k | -US$5m |
| Jan 31 2023 | n/a | n/a | -US$3m |
| Oct 31 2022 | n/a | n/a | US$108k |
| Jul 31 2022 | n/a | n/a | US$401k |
| Apr 30 2022 | US$800k | US$400k | US$548k |
| Jan 31 2022 | n/a | n/a | US$219k |
| Oct 31 2021 | n/a | n/a | US$391k |
| Jul 31 2021 | n/a | n/a | US$115k |
| Apr 30 2021 | US$775k | US$375k | US$362k |
| Jan 31 2021 | n/a | n/a | -US$1m |
| Oct 31 2020 | n/a | n/a | -US$2m |
| Jul 31 2020 | n/a | n/a | -US$1m |
| Apr 30 2020 | US$1m | US$394k | -US$2m |
| Jan 31 2020 | n/a | n/a | -US$181k |
| Oct 31 2019 | n/a | n/a | -US$956k |
| Jul 31 2019 | n/a | n/a | -US$995k |
| Apr 30 2019 | US$146k | US$146k | US$128k |
| Jan 31 2019 | n/a | n/a | -US$251k |
| Oct 31 2018 | n/a | n/a | US$42k |
| Jul 31 2018 | n/a | n/a | -US$320k |
| Apr 30 2018 | US$244k | n/a | -US$1m |
Compensación vs. Mercado: La compensación total ($USD600.00K) de Ronnie está en línea con el promedio de empresas de tamaño similar en el mercado US ($USD667.11K).
Compensación vs. Ingresos: La compensación de Ronnie ha sido consistente con los resultados de la empresa en el último año.
CEO
Ronnie Morris (57 yo)
7.3yrs
Permanencia
US$600,000
Compensación
Dr. Ronnie Morris, M.D. has been Chief Executive Officer at Champions Oncology, Inc. since January 31, 2017. Dr. Morris previously served as the President and a Director of Champions Oncology, Inc. from Oc...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & Director | 7.3yrs | US$600.00k | 6.32% $ 4.2m | |
| Chief Financial Officer | 7yrs | US$294.30k | 0.041% $ 26.7k | |
| President | less than a year | sin datos | sin datos | |
| Chief Operating Officer | less than a year | sin datos | sin datos | |
| Vice President of Technology | 4yrs | sin datos | sin datos | |
| VP of Global Marketing | no data | sin datos | sin datos | |
| Executive Vice President of Global Laboratory Operations | 2.7yrs | sin datos | sin datos | |
| Chief Commercial Officer | no data | sin datos | sin datos | |
| Executive Vice President of Global Scientific Operations | 2.7yrs | sin datos | sin datos | |
| Executive Vice President of Commercial | less than a year | sin datos | sin datos |
2.7yrs
Permanencia media
Equipo directivo experimentado: El equipo directivo de CSBR se considera experimentado (2.6 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO & Director | 13.6yrs | US$600.00k | 6.32% $ 4.2m | |
| Independent Director | 12.9yrs | US$88.42k | 0.22% $ 145.5k | |
| Independent Chairman of the Board | 13.6yrs | US$110.53k | 6.3% $ 4.2m | |
| Independent Lead Director | 16.8yrs | US$82.89k | 5.64% $ 3.7m | |
| Scientific Advisor | no data | sin datos | sin datos | |
| Scientific Advisor | no data | sin datos | sin datos | |
| Independent Director | 11.2yrs | US$81.05k | 1.46% $ 963.3k | |
| Scientific Advisor | no data | sin datos | sin datos | |
| Independent Director | 8.1yrs | US$82.89k | 0.11% $ 71.0k | |
| Board Observer | no data | sin datos | sin datos | |
| Scientific Advisor | no data | sin datos | sin datos | |
| Independent Director | 3.3yrs | US$78.94k | 0% $ 0 |
12.9yrs
Permanencia media
57.5yo
Promedio de edad
Junta con experiencia: Los miembros de la junta directiva de CSBR son experimentados ( 12.8 años antigüedad media).